ClinicalTrials.gg
RecruitingNCT06270589Updated Jun 29, 2026

Acute Effects of High-intensity Interval Training With Mindfulness-based Recovery on Executive Function in Children

An interventional study of MF-HIIT and MF-only in Healthy Volunteers, sponsored by Purdue University. Recruiting at 1 site in United States. Open to participants aged 10 Years to 12 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-29.

Sponsored by Purdue University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jun 2024; still recruiting 2 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Non-randomized
Ages
10 Years to 12 Years
Sex
All
01

Study summary

The goal of this randomized cross-over trial is to learn about the effect of a single bout of 20-min mindfulness-based high-intensity interval training (MF-HIIT), MF-only, and HIIT-only in relative to sitting rest on executive function (EF) in 10-12 years old children. The main question it aims to answer are:

Question 1: Whether a single bout of 20-min MF-HIIT has larger beneficial effect on EF performance than that following a 20-min session of MF-only and HIIT-only in relative to the sitting rest

Question 2: Whether a single bout of 20-min MF-HIIT has a larger beneficial effect on brain functioning, as measured by the N2 and P3 components of event-related potential (ER) during EF performance than that following a 20-min session of MF-only and HIIT-only in relative to the sitting rest

Participants will visit the laboratory on 5 separate days (> 2-day washout between days) in which they have not previously participated in structured physical activities.

Participants will complete the testing and/or receive treatments below:

Day 1:

  • Kaufman Brief Intelligence Test (KBIT) to assess intelligence quotient
  • Treadmill-based exercise test to measure cardiorespiratory fitness (maximum oxygen consumption)

Days 2-5

  • Each day, participants will complete each of the four intervention conditions (MF-HIIT, MF-only, HIIT-only, sitting)
  • Participants' heart rate and self-reported affect and rating of physical exertion will be measured
  • Participants will complete a modified flanker task and a task-switching task to assess inhibitory control and cognitive flexibility
  • Participants will wear an EEG cap to measure the N2 and P3 components of the event-related potential during the inhibitory control and cognitive flexibility performance

Researcher will compare the cognitive outcome measures following the MF-HIIT, MF-only, and HIIT-only conditions with the sitting condition to see if MF and HIIT has beneficial effects on children's EF.

Further, researcher will compare the cognitive outcome measures following the MF-HIIT compared with MF-only and HIIT-only conditions to see if combining MF with HIIT has greater beneficial effects on children's EF than MF and HIIT alone.

02

Conditions studied

  • Healthy Volunteers

Keywords

  • Interval Exercise
  • Mindfulness
  • Executive function
  • Brain function
  • Children
03

In context

Lead sponsor

Purdue University is the lead sponsor of 175 studies on the registry; 21 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
10 Years to 12 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age between 10-12 years old
  • Intelligence Quotient ≥ 85
  • Capable of performing exercise based on pre-participation health screening
  • No formal diagnosis of cognitive disorders (e.g., attention deficit hyperactivity disorder) and neurological diseases (e.g., epilepsy)

Exclusion criteria

Exclusion Criteria:

  • Age outside of the range of 10-12 years old
  • Intelligence Quotient \< 85
  • No capable of performing exercise based on pre-participation health screening
  • Has formal diagnosis of cognitive disorders (e.g., attention deficit hyperactivity disorder) and neurological diseases (e.g., epilepsy)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Crossover assignment
Masking
Single (Outcomes assessor)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    A Single Bout Of Mindful High-Intensity Interval Training (Mindful HIIT)

    Behavioral: MF-HIIT

  • Active comparator
    A Single Bout Of High-Intensity Interval Training (HIIT)

    Behavioral: HIIT-only

  • Active comparator
    A Single Bout Of Mindfulness

    Behavioral: MF-only

  • Other
    A Single Bout Of Sitting Rest

    Behavioral: Sitting rest

Interventions

  • BehavioralMF-HIIT

    A single bout of 20-min MF-HIIT protocol delivered through a motor-driven treadmill. The protocol will start with a 1.5-min warm-up, then a 16.5-min main exercise (6 x 90s exercise intervals separated by 5 x 90s mindful intervals), and finally a 2-min cool-down.

  • BehavioralMF-only

    A single bout of 20-min intervention mindfulness intervention that includes 5 x 90s mindful intervals separated by sitting rest

  • BehavioralHIIT-only

    A single bout of 20-min HIIT protocol delivered through a motor-driven treadmill. The protocol will start with a 1.5-min warm-up, then a 16.5-min main exercise (6 x 90s exercise intervals separated by 5 x 90s rest intervals), and finally a 2-min cool-down.

  • BehavioralSitting rest

    Participants will sit in a comfortable chair, placed on the treadmill, while watching a HIIT video without mindfulness instructions for 20 minutes.

06

What researchers measure

Primary outcomes

  1. Inhibition speed

    Inhibition speed will be assessed by the response time (ms) during a child-friendly flanker task.

    Time frame: At the baseline before and about 10-min after the 20-min intervention on Day 2, Day 3, Day 4, and Day 5.

  2. Inhibition accuracy

    Inhibition accuracy will be assessed by the response accuracy (%) during a child-friendly flanker task.

    Time frame: At the baseline before and about 10-min after the 20-min intervention on Day 2, Day 3, Day 4, and Day 5.

  3. Shifting speed

    The shifting speed will be assessed by the response time (ms) during a child-friendly switching task.

    Time frame: At the baseline before and about 10-min after the 20-min intervention on Day 2, Day 3, Day 4, and Day 5.

  4. Shifting accuracy

    The shifting accuracy will be assessed by the response accuracy (%) during a child-friendly switching task.

    Time frame: At the baseline before and about 10-min after the 20-min intervention on Day 2, Day 3, Day 4, and Day 5.

  5. N2-ERP

    The N2 component of event-related brain potentials is a neuroelectric index of conflict processing. Increased amplitude of N2 reflects increased neural activation to detect and resolve conflicts.

    Time frame: At the baseline before and about 10-min after the 20-min intervention on Day 2, Day 3, Day 4, and Day 5.

  6. P3-ERP

    The P3 component of event-related brain potentials is a neuroelectric index of attention. Increased amplitude of P3 reflects greater allocation of attentional resources and the decreased latency of P3 reflects the faster information processing speed.

    Time frame: At the baseline before and about 10-min after the 20-min intervention on Day 2, Day 3, Day 4, and Day 5.

Secondary outcomes

  1. State Mindfulness Scale for Physical Activity (SMSPA)

    A developmentally-appropriate and validated 12-item, 5-point Likert scaled (0-4), instrument to measure self-reported mindfulness state in children aged above 10 years old. This measure will serve as a manipulation check on mindfulness induction during each of the 4 intervention conditions.

    Time frame: Immediately after completing the 20-min intervention on Day 2, Day 3, Day 4, and Day 5.

  2. Rating of perceived exertion

    The 10-point Children's OMNI rating of perceived exertion will be used as a manipulation check on the intensity of prescribed exercise for the school-based programs as well as the laboratory-based acute interventions.

    Time frame: Measure at 0 second, 90 seconds, 180 seconds, 270 seconds, 360 seconds, 450 seconds, 540 seconds, 630 seconds, 720 seconds, 810 seconds, 900 seconds, 990 seconds, 1080 seconds and 1200 seconds of the 20-min intervention on Day 2, Day 3, Day 4, and Day 5.

  3. Heart Rate

    Heart rate will serve as a manipulation check on the intensity of prescribed exercise.

    Time frame: Heart rate will be measured at every minute (minutes 0, 1, 2, 3, 4, ...., 18, 19, 20) during the 20-min intervention on Day 2, Day 3, Day 4, and Day 5.

Other outcomes

  1. Dispositional mindfulness

    Child and Adolescent Mindfulness Measure (CAMM) provides a validated and reliable measure of dispositional mindfulness in children using 10 items and 5-point Likert scale (0-4), with a higher total score indicating the participant is more mindful. This measure will be used as the secondary outcome measure to to check the intervention manipulation.

    Time frame: At baseline on Day 1 before receiving any intervention

07

Study locations

1 of 1 sites recruiting
  • Lambert, 800 West Stadium Avenue
    West Lafayette, Indiana 47907, United States
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06270589
Lead sponsor
Purdue University
Collaborators
University of Oregon
Responsible party
Shih-Chun Kao (Assistant Professor, Purdue University) — Principal investigator
First posted
Feb 21, 2024
Start date
Jun 15, 2024
Primary completion
May 31, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Jun 29, 2026

Study contacts

Shih-Chun Kao, PhD
Contact
kao28@purdue.edu
765-496-2213

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion